Press Release Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026 Century Therapeutics, Inc. · Jul 9
Press Release CCC Intelligent Solutions Announces Date of Second Quarter 2026 Earnings Call CCC Intelligent Solutions · Jul 9
Press Release Eos Energy Announces a Virtual Investor Presentation for Rights Offering Eos Energy Enterprises, Inc. · Jul 9
Press Release ROC Receives U.S. Department of Homeland Security SAFETY Act DT&E Designation for ROC Watch ROC · Jul 9
Press Release Byrna Technologies Reports Fiscal Second Quarter 2026 Results Byrna Technologies, Inc. · Jul 9
Press Release Atsena Therapeutics Selects ATSN-401 Clinical Candidate, a Potential Best-in-Class Gene Therapy for Stargardt Disease Atsena Therapeutics · Jul 9
Press Release EVTV Files Corporate Name Change to Azio AI Following Completed Merger; Announces $27.9 Million AI Infrastructure Hosting Agreement with Power Champion, Scalable to 12 MW Under Contracted Expansion Rights Envirotech Vehicles · Jul 9
Press Release Alignment Healthcare to Announce Second Quarter 2026 Financial Results and Host Conference Call Thursday, July 30, 2026 Alignment Healthcare USA, LLC · Jul 9
Press Release Phoenix Tailings Appoints Patrick Kumashiro, Former Department of War F-35 Joint Strike Fighter Senior Advisor, as Chief Strategy Officer Phoenix Tailings, Inc. · Jul 9
Press Release IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma IN8bio, Inc · Jul 9
Press Release Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner Vera Therapeutics · Jul 9